EU Regulators Propose Additional Data Requirements For Device Trials
This article was originally published in The Gray Sheet
Executive Summary
The European Commission's Clinical Evaluation Task Force (CETF) expects the EC to publish guidance by year-end detailing when literature submissions alone are sufficient for device trials to comply with the EU Medical Device Directive
You may also be interested in...
EU Commission Advised To Consider Special CE Mark For Medical Devices
European manufacturers are proposing that the EU Commission establish a device-specific "CEMed" quality system to bolster the image of the CE mark and discourage the proliferation of additional quality marks in Europe
EU Commission Advised To Consider Special CE Mark For Medical Devices
European manufacturers are proposing that the EU Commission establish a device-specific "CEMed" quality system to bolster the image of the CE mark and discourage the proliferation of additional quality marks in Europe
Boston Scientific Liberty Stent Groomed To Face Next-Gen Cobalt Competitors
Boston Scientific will enroll approximately 400 patients in an ongoing clinical trial to support a PMA supplement for the firm's Taxus Liberty stent platform